▶ 調査レポート

消費者直接型(DTC)臨床試験の日本市場2021-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; and Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others) - Japan Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Transparency Market Researchが調査・発行した産業分析レポートです。消費者直接型(DTC)臨床試験の日本市場2021-2031:産業分析、規模、シェア、成長、動向、予測 / Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; and Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others) - Japan Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / MRC2206A081資料のイメージです。• レポートコード:MRC2206A081
• 出版社/出版日:Transparency Market Research / 2022年4月
• レポート形態:英文、PDF、84ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートでは、日本の消費者直接型(DTC)臨床試験市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検体タイプ別分析、検査種類別分析、地域別分析、競争状況などの内容をまとめております。

Japan Direct-to-Consumer Laboratory Testing Market – Scope of Report
TMR’s report on the direct-to-consumer laboratory testing market in Japan studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the direct-to-consumer laboratory testing market in Japan for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the direct-to-consumer laboratory testing market in Japan from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the direct-to-consumer laboratory testing market in Japan.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the direct-to-consumer laboratory testing market in Japan.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the direct-to-consumer laboratory testing market in Japan. These serve as valuable tools for existing market players as well as for entities interested in participating in the direct-to-consumer laboratory testing market in Japan.

The report delves into the competitive landscape of the direct-to-consumer laboratory testing market in Japan. Key players operating in the direct-to-consumer laboratory testing market in Japan have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the direct-to-consumer laboratory testing market in Japan profiled in this report.

Key Questions Answered in Japan Direct-to-Consumer Laboratory Testing Market Report
What is the sales/revenue generated by direct-to-consumer laboratory testing in Japan during the forecast period?
What are the opportunities in the direct-to-consumer laboratory testing market in Japan?
What are the major drivers, restraints, opportunities, and threats in the market?
Is market set to expand at the fastest CAGR during the forecast period?
Which sample type is expected to generate the highest revenue in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market position of different companies operating in the market?

Japan Direct-to-Consumer Laboratory Testing Market – Research Objectives and Research Approach
The comprehensive report on the direct-to-consumer laboratory testing market in Japan begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the direct-to-consumer laboratory testing market in Japan, in terms of sample type, test type, and region. Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the direct-to-consumer laboratory testing market in Japan.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Japan Direct-to-Consumer Laboratory Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Sample Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Epidemiology
5.2. Regulatory Scenario by Country
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017–2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type
7. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017–2031
7.3.1. Genetic Testing
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Cancer
7.3.2.2. STDs
7.3.2.3. Others
7.3.3. CBC
7.3.4. TSH Testing
7.3.5. Diabetes Testing
7.3.6. Others
7.4. Market Attractiveness Analysis, by Test Type
8. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. Japan
8.3. Market Attractiveness Analysis, by Country/Region
9. Competition Landscape
9.1. Market Player – Competition Matrix (by tier and size of companies)
9.2. Company Profiles
9.2.1. Quest Diagnostics Incorporated
9.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.1.2. Product Portfolio
9.2.1.3. Financial Overview
9.2.1.4. Strategic Overview
9.2.1.5. SWOT Analysis
9.2.2. WellnessFX
9.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.2.2. Product Portfolio
9.2.2.3. Financial Overview
9.2.2.4. Strategic Overview
9.2.2.5. SWOT Analysis
9.2.3. Ulta Lab Tests, LLC
9.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.3.2. Product Portfolio
9.2.3.3. Financial Overview
9.2.3.4. Strategic Overview
9.2.3.5. SWOT Analysis
9.2.4. Walk-In Lab, LLC
9.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.4.2. Product Portfolio
9.2.4.3. Financial Overview
9.2.4.4. Strategic Overview
9.2.4.5. SWOT Analysis
9.2.5. Genesis Healthcare Co.
9.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.5.2. Product Portfolio
9.2.5.3. Financial Overview
9.2.5.4. Strategic Overview
9.2.5.5. SWOT Analysis
9.2.6. MyHeritage Ltd.
9.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.6.2. Product Portfolio
9.2.6.3. Financial Overview
9.2.6.4. Strategic Overview
9.2.6.5. SWOT Analysis
9.2.7. Gene by Gene, Ltd.
9.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.7.2. Product Portfolio
9.2.7.3. Financial Overview
9.2.7.4. Strategic Overview
9.2.7.5. SWOT Analysis
9.2.8. Full Genomes Corporation, Inc.
9.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.8.2. Product Portfolio
9.2.8.3. Financial Overview
9.2.8.4. Strategic Overview
9.2.8.5. SWOT Analysis
9.2.9. OME Care
9.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.9.2. Product Portfolio
9.2.9.3. Financial Overview
9.2.9.4. Strategic Overview
9.2.9.5. SWOT Analysis

List of Tables

Table 01: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 04: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031